🇺🇸 Intradialytic parenteral nutrition in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 5

Most-reported reactions

1. Asthenia — 1 report (20%)
2. Hypotension — 1 report (20%)
3. Lung Neoplasm Malignant — 1 report (20%)
4. Nausea — 1 report (20%)
5. Pneumonia — 1 report (20%)

Source database →

Frequently asked questions

Is Intradialytic parenteral nutrition approved in United States?

Intradialytic parenteral nutrition does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Intradialytic parenteral nutrition in United States?

EZUS-LYON 1 is the originator. The local marketing authorisation holder may differ — check the official source linked above.